Representative Casten believes that Americans have a right to universal, quality, affordable health care. As a member of the New Dem Health Taskforce, he stands solidly behind efforts to protect and strengthen the Affordable Care Act (ACA). Thanks to the ACA, insurance companies can no longer discriminate against people pre-existing conditions or by age, young people can stay on their parents’ health plan until they turn 26, and all insurance plans must cover essential health benefits like maternity care, hospital stays, and prescription drugs.

We must work together in a bipartisan way to strengthen and improve the Affordable Care Act. Rep Casten is a cosponsor of H.R.1884, the Protecting Pre-Existing Conditions & Making Health Care More Affordable Act of 2019 which would:

  • Lower health insurance premiums with strengthened and expanded affordability assistance
  • Strengthen protections for people with pre-existing conditions
  • Stop insurance companies from selling junk health insurance plans
  • Reverse the GOP’s health care sabotage that has needlessly driven up premiums and uninsured rates, and empower states to innovate and invest in enrolling more people in affordable health coverage

Lowering Health Care Costs:

Rep. Casten is also working to lower the cost of health care which still remains too high and out of reach for far too many. He has introduced the FLAT Prices Act which would target unfair price hikes for prescription drugs. The legislation imposes penalties on pharmaceutical companies who harm consumers with sudden, exorbitant price increases and promotes competition among manufacturers to lower drug prices.

He has also cosponsored legislation, H.R.1046, the Medicare Negotiation and Competitive Licensing Act, that would directly allow Medicare to negotiate the price taxpayers pay for prescription drugs. In 2018, Americans spent an all-time high of $360 billion on prescription drugs. According to a 2016 Consumer Reports survey, 30 percent of Americans who experienced an increase in the price of one or more of their medications left a prescription unfilled because it was too expensive; 15 percent said they cut pills in half to make them last longer. This bill would authorize the Secretary of Health and Human Services to negotiate drug prices and, if drug companies refuse to negotiate in good faith, it would enable the Secretary to issue a competitive license to another company to produce the medication as a generic.

Women’s Health:

As a member of the Pro-Choice Caucus, Rep. Casten strongly believes in a women’s right to choose. Politicians have no place in the extremely personal and complex decision-making process between a woman and her doctor.  The Congressman opposes anti-choice actions that limit women’s access to abortion and birth control. Rep Casten will continue to fight for the constitutionally protected rights for American women.

More on Healthcare

April 13, 2020 Press Release

Downers Grove, IL – Recognizing the mounting fear and isolation felt by Illinois residents 60+, who are at increased risk for serious illness from the novel Coronavirus 2019 (COVID-19), U.S. Representative Sean Casten (IL-06) and family physician and Board Member of the Illinois Academy of Family Physicians, Dr. Kate Rowland held a live telephone town hall with thousands of older adults from the 6th Illinois Congressional District on Monday.

April 1, 2020 Page

FAQs: Health Care Provisions in the Coronavirus Aid, Relief, and Economic Security (CARES) Act:



How much funding is included in the Public Health and Social Services Emergency Fund (PHSSEF) for assistance for hospitals and health care providers? Who is eligible for the funding? 

February 28, 2020 Press Release

Washington, D.C. – Today, U.S. Representative Sean Casten (IL-06) released the following statement after the House passed H.R. 2339 the Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2019 by a vote of 213-195.

February 25, 2020 Press Release

Washington, D.C. – Today, U.S. Representative Sean Casten (IL-06) released the following statement condemning the U.S. Senate’s vote to end debate on two bills designed to limit abortion rights, S. 3275 the Pain-Capable Unborn Child Protection Act and S. 311 the Born-Alive Abortion Survivors Protection Act.

February 20, 2020 Press Release

Glen Ellyn, IL – Today, U.S. Representative Sean Casten (D-IL-06), along with U.S. Representatives Cindy Axne (D-IA-03), Don Bacon (R-NE-02), and Peter King (R-NY-02) sent a bipartisan letter to several federal agencies requesting assistance for federal workers who will need paid family leave.

February 12, 2020 In The News

In the wake of the State of the Union address delivered by President Donald Trump last week, U.S. Rep. Sean Casten said he felt compelled to talk about the condition of our democracy at a town hall Saturday afternoon at the Ganek Municipal Center in Algonquin.

December 16, 2019 In The News

With just days left to enroll for health insurance coverage through the Affordable Care Act, local, state and federal officials are encouraging residents to take advantage of the program.

Anyone who doesn't have health insurance through an employer, Medicare, Medicaid, the Children's Health Insurance Program or another source has until the end of the day Sunday to enroll in a plan through the Health Insurance Marketplace at

December 13, 2019 In The News

SPRINGFIELD, Ill., Dec. 12, 2019 /PRNewswire/ -- AARP Illinois State Director Bob Gallo released the following statement today, applauding Reps. Cheri Bustos, Sean Casten, Danny K. Davis, Bill Foster, Raja Krishnamoorthi, Dan Lipinski, Jesus "Chuy" García, Robin Kelly, Mike Quigley, Bobby Rush, Jan Schakowsky, Brad Schneider and Lauren Underwood of the U.S. House of Representatives for voting to pass H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act.

December 12, 2019 Press Release

Washington, D.C. – Today, U.S. Representative Sean Casten (IL-06) voted for the bipartisan H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act. The bill would finally provide Americans relief from skyrocketing drug prices by allowing the Secretary of Health and Human Services the tools to negotiate lower prices, capping annual out-of-pocket costs in Medicare Part D, and reversing years of unfair price hikes above inflation across thousands of drugs in Medicare.